Skip to main content
Clinical Trials/NCT04305509
NCT04305509CompletedNot Applicable

Outcomes After Chiropractic Spinal Manipulative Therapy for Patients With Lumbar Disc Herniation and Radiculopathy

Balgrist University Hospital1 site in 1 country98 target enrollmentStarted: March 9, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
98
Locations
1
Primary Endpoint
intensity of low back pain

Study Overview

Brief Summary

In a study that was approved nine years ago (EK-22/2009) we could show (i) that spinal manipulative therapy (SMT) is a very effective and safe treatment for acute and chronic lumbar disc herniation (LDH); (ii) that SMT is as effective and less expensive than lumbar nerve root injections and (iii) that the recurrence rate up to one year was very low in acute and in chronic LDH patients. However, the long-term outcome of this conservatively treated LDH patients is unknown. Thus, the objective of this amendment is to investigate the proportion of long-term recurrences in these patients who were treated with SMT for their LDH and to compare these results with already existing data from other treatments, e.g. surgery. This is important information to know whether this conservative method is a sustainable approach for treating LDH.

Detailed Description

All 148 patients with magnetic resonance imaging-confirmed disc herniation who were recruited for the study EK 22-2009 will be re-contacted to assess the course of their back problem during the past approx. nine years using a questionnaire.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •The same patients who were recruited for the study EK-22/2009

Exclusion Criteria

  • •The same as for study EK-22/2009:
  • •Patients with specific pathologies of the lumbar spine that are contraindications to chiropractic manipulative treatment, such as tumors, infections, inflammatory spondylarthropathies, acute fractures, Paget's disease and severe osteoporosis, will be excluded. Also excluded will be patients with previous spinal surgery, signs of cauda equina syndrome (CES), sequestration of disc material, body mass index >30, spondylolisthesis, neurogenic claudication and pregnancy.

Outcomes

Primary Outcomes

intensity of low back pain

Time Frame: 1 month

intensity of low back pain in the last month (numeric rating scale)

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Balgrist University Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Brigitte Wirth

Senior scientist Chiropractic Medicine

Balgrist University Hospital

Study Sites (1)

Loading locations...

Similar Trials